Smart Rings, AI Wearables and Health Apps: Business Models, Subscription Revenue and Evidence (2026)

Updated October 30, 2026

Smart rings, AI-powered wearables and health apps are transforming consumer healthcare into a continuous-data business. Instead of relying on occasional doctor visits or annual health checks, consumers can monitor sleep, heart rate, activity, recovery, stress and selected physiological signals throughout the day.

For technology companies and investors, the more important development is not simply the sale of another wearable device. It is the opportunity to turn a physical product into an ongoing relationship through recurring subscriptions, personalized analytics, AI coaching, health services and business-to-business partnerships.

However, a commercially successful wearable is not necessarily a clinically effective one. Accurate measurement of a physiological signal does not automatically translate into a reliable disease prediction, a better health outcome or a reduction in healthcare costs.

This independent analysis examines the business models, revenue economics, competing platforms and scientific evidence behind the wearable-health industry. It distinguishes reported financial results and documented product features from management expectations, promotional claims and clinical hypotheses that still require validation.

Key Takeaways

• The hardware-plus-subscription model is becoming an important competitive strategy. Companies can generate an initial device sale and then recurring revenue from software, analytics and personalized health insights.
• Subscription revenue is not the same as subscription profitability. Investors must examine retention, customer acquisition costs, hardware margins, support expenses and the cost of maintaining the platform.
• Not every company requires a subscription. Oura charges for membership, WHOOP bundles hardware and software into membership plans, while Samsung provides Galaxy Ring health data through Samsung Health without an additional ring-data subscription.
• AI is a product feature, not proof of medical effectiveness. The value of an AI-generated recommendation depends on the quality of the underlying measurements, the validity of the algorithm and the usefulness of the advice.
• Wearables have more established evidence for some purposes than others. Activity monitoring and behavioral feedback can encourage physical activity, but evidence for broad improvements in disease outcomes remains inconsistent.
• The strongest long-term opportunity may be the service layer. Health coaching, clinical integrations, remote monitoring, employer wellness and validated decision-support tools could create additional revenue streams beyond consumer hardware.

1. What Is the Smart Ring and AI Wearable Business?

The wearable-health ecosystem consists of several connected layers. Each layer may have a different cost structure, competitive advantage and revenue model.

Layer 1: Hardware and sensors

Devices collect physiological or behavioral information using sensors such as photoplethysmography (PPG), accelerometers, gyroscopes, temperature sensors and, in selected devices, electrocardiography (ECG).

Examples include smart rings, smartwatches, fitness bands and specialized medical-monitoring devices.

The commercial challenge is to make the hardware comfortable, reliable, affordable and durable enough for people to wear consistently. Finger-worn devices can be attractive for overnight monitoring because they lack a bright display and may be more comfortable to sleep in than some wrist-worn devices.

Layer 2: Software and data processing

Raw sensor signals are converted into estimates such as resting heart rate, sleep duration, activity levels, heart rate variability (HRV) and physiological trends.

This layer may include proprietary algorithms, signal-processing systems, cloud infrastructure, data synchronization and integrations with other health platforms.

Its economic advantage is that software can potentially serve additional customers without manufacturing another physical product. However, cloud computing, customer support, data security, research and development are ongoing expenses.

Layer 3: AI and personalized insights

AI systems may summarize trends, identify changes from an individual's baseline, recommend adjustments to sleep or training routines, and provide conversational explanations of health metrics.

There is an important distinction between conventional predictive algorithms and generative AI assistants. A model that estimates a sleep score is not necessarily the same technology as a conversational AI that explains the score. Both require appropriate validation for the claims they make.

Layer 4: Services and distribution

The final layer includes premium memberships, coaching, integrations with healthcare professionals, research partnerships, corporate wellness programs and selected clinical services.

This layer potentially creates more durable customer relationships because a platform can become useful across different life stages and health goals.

The business opportunity is strongest when each layer improves the value of the others. Better hardware can generate more consistent data, better software can make those data more useful, and useful insights can encourage retention.

2. The Market Is Shifting from Device Sales to Recurring Revenue

Traditional consumer electronics businesses generally depend heavily on hardware sales and replacement cycles. Wearable-health companies have an opportunity to add recurring revenue through subscriptions and digital services.

Sensor Tower's October 2026 report estimated that wearable-related apps generated 244 million downloads worldwide in the first three quarters of 2026. In-app purchase revenue increased 30% to an estimated $139 million over the same period.

These figures cover a defined category of wearable-related applications, including apps for smartwatches, fitness bands and smart rings. They do not represent the entire wearable hardware market, all health-app revenue or the total revenue of device manufacturers.

Even with that limitation, the figures illustrate a commercially important distinction: app downloads measure adoption, while in-app purchases provide a more direct indicator of monetization through paid digital features.

Source: Sensor Tower, State of Wearable Technology 2026.

Why recurring revenue appeals to investors

• Predictability: A retained subscriber can generate revenue beyond the original purchase date.
• Customer lifetime value: Multiple years of membership may increase the total revenue earned from each customer.
• Software scalability: A successful platform can potentially add users without a proportionate increase in manufacturing expenditure.
• Continuous product development: Subscription income can fund new features, algorithm improvements and additional health insights.
• Distribution opportunities: An established user base can support family plans, employer programs, partnerships and additional services.

These advantages are not automatic. Recurring revenue can conceal high customer acquisition costs, rising churn, expensive service delivery or dependence on continual hardware upgrades.

3. Oura: A Leading Example of the Hardware-Plus-Subscription Model

Oura combines smart ring sales with a paid membership that provides access to a broader collection of health metrics, reports and personalized insights.

Its business model is particularly useful for understanding how a consumer wearable can develop a substantial software revenue stream without becoming a pure software company.

Oura's reported financial performance

Oura's 2026 registration statement filed with the US Securities and Exchange Commission reported the following results:

• Fiscal 2025 revenue: approximately US$907.9 million.
• Revenue for the nine months ended June 30, 2026: approximately US$1.215 billion, compared with US$697.6 million in the corresponding 2025 period.
• Hardware revenue for the nine-month 2026 period: approximately US$974.0 million.
• Membership revenue for the nine-month 2026 period: approximately US$240.5 million, compared with US$108.8 million in the corresponding 2025 period.
• Membership share of revenue: approximately 20% during the nine months ended June 30, 2026.
• Membership gross margin: approximately 89% during that nine-month period.
• Paid members: approximately 5.0 million at June 30, 2026.

Source: Oura's SEC registration statement and financial disclosures.

These are company-reported figures. The nine-month results must not be confused with full-year results or annualized forecasts.

What the numbers reveal

First, hardware remains the dominant revenue source. Oura is not simply a software subscription business disguised as a technology company.

Second, membership revenue increased substantially faster than hardware revenue during the first nine months of fiscal 2026. Membership revenue increased approximately 121% year over year, while hardware revenue increased approximately 65%.

Third, membership gross margin was materially higher than the company's consolidated gross margin. This is consistent with the economics of a software service attached to a physical product, although subscription gross margin does not include every corporate expense and should not be confused with net profit margin.

Fourth, the membership model has the potential to increase the value of an existing customer relationship. An initial ring purchase may be followed by recurring payments, new features and eventual hardware replacement.

How large is Oura's subscription opportunity?

Oura's proposed US initial public offering was postponed in September 2026 amid market uncertainty. Subsequent reporting on October 22 indicated that the company had surpassed six million paying subscribers.

Source: Associated Press coverage of Oura's postponed IPO; The Wall Street Journal's October 2026 subscriber report.

The distinction between the June financial disclosures and the later subscriber milestone matters. The six-million figure is a later reported operating milestone, not an audited full-year revenue figure.

As of October 30, 2026, Oura's proposed Nasdaq listing had been postponed. Its proposed ticker, OURA, should not be treated as an already-trading public stock.

Oura's subscription pricing

Oura's US membership page lists pricing of US$5.99 per month or US$69.99 per year, with a free first month for eligible new members. Prices and terms differ across regions.

Source: Official Oura Membership page.

At the US monthly list price, a continuously paying member represents US$71.88 in gross annualized subscription billings before cancellations, discounts, taxes and other adjustments. Annual-plan members pay a different effective monthly rate.

This is an illustrative calculation, not a forecast of actual company revenue. Actual results depend on subscriber mix, geographic pricing, activation, payment timing, retention and other factors.

The key economic lesson

Oura demonstrates that a successful consumer wearable can combine an upfront hardware sale with recurring digital revenue. However, its financial performance also demonstrates why analysts must examine hardware revenue, subscription revenue and their respective margins separately.

A high subscription gross margin is attractive, but it does not remove the need to design, manufacture, distribute and replace physical products.

4. WHOOP: Membership as the Core Product

WHOOP emphasizes continuous monitoring, fitness, recovery, sleep and personalized coaching. Rather than positioning itself primarily as a conventional watch manufacturer, it structures its consumer offering around membership plans that include compatible hardware.

According to its official US pricing page, the membership tiers listed in 2026 are:

• WHOOP One: US$199 per year, covering core fitness, strain, recovery and sleep insights with personalized coaching.
• WHOOP Peak: US$239 per year, adding features such as health monitoring, stress monitoring and healthspan insights.
• WHOOP Life: US$359 per year, adding a compatible medical-grade sensor and selected features such as ECG readings and irregular heart rhythm notifications, subject to regional availability and regulatory restrictions.

Source: Official WHOOP Membership Pricing guide.

These are US prices. Plan terms, included hardware and available features can vary by market. Membership is generally billed annually, with monthly arrangements available only in specified circumstances.

Why the WHOOP model matters

• Recurring monetization is central: Hardware is supplied as part of a continuing membership relationship.
• Tiered pricing supports segmentation: Casual users and more demanding fitness users can be offered different levels of functionality.
• Coaching reinforces engagement: Personalized feedback may make the platform more useful than a device that simply displays measurements.
• Feature differentiation encourages upgrades: Additional metrics and services can justify higher-priced plans if customers find them valuable.

This model makes retention particularly important. A customer who leaves is not merely a lost opportunity for future software revenue; the company may also need to replace that customer through additional marketing and distribution expenditure.

Membership pricing alone does not reveal WHOOP's profitability. A proper financial assessment would require reliable information on subscriber numbers, acquisition costs, hardware expenditure, retention cohorts and operating expenses.

5. Samsung Galaxy Ring: Hardware Sales Without a Ring-Data Subscription

Samsung Galaxy Ring illustrates an alternative business model.

Samsung's Singapore product page states that Galaxy Ring health data can be accessed through the Samsung Health app without an additional subscription fee for the ring's health data. Samsung's US product page has listed the device at US$399.99, although regional pricing and promotions differ.

Sources: Samsung Singapore Galaxy Ring information; Samsung US Galaxy Ring pricing.

The commercial strategy is different from a mandatory membership model. Samsung can monetize the device through its hardware business while strengthening engagement with its Galaxy ecosystem, smartphones and health software.

The absence of a ring-data subscription does not mean that every Samsung service or AI feature will necessarily remain free forever. Individual services can have separate terms, availability restrictions or future pricing changes.

Advantages of a no-mandatory-subscription strategy

• The consumer understands the basic purchase cost upfront.
• There is less friction from recurring billing.
• The company can use the wearable to reinforce an existing device ecosystem.
• The platform can potentially benefit through hardware loyalty and cross-selling rather than a direct ring subscription.

Potential disadvantages

• Recurring consumer revenue may be less direct.
• The company must justify hardware pricing through features, quality and ecosystem value.
• Long-term software development must be funded through a broader business model.

This approach may be attractive for manufacturers with a diversified hardware and services business. It may be more difficult for a standalone wearable startup that depends on a single product category.

6. Ultrahuman: Hardware Plus Optional Digital Services

Ultrahuman offers another approach through the Ring AIR and its associated software features.

Its official pricing pages have listed the Ring AIR at US$349 in the United States, with no mandatory subscription required for the core ring-data experience. The company also offers optional software add-ons, known as PowerPlugs, for selected features. The price and availability of these services vary by market and product.

Source: Official Ultrahuman Ring pricing and feature information.

This model separates the basic device experience from optional paid capabilities.

Commercially, the advantage is that users can begin with the core product and purchase specialist features when they perceive additional value. The challenge is that each add-on must deliver sufficient incremental utility to justify its price.

Optional services may be particularly suitable for specialized health interests, provided that each feature is supported by appropriate evidence and does not imply clinical benefits beyond what has been demonstrated.

7. The Main Business Models for AI Wearables and Health Apps

Companies do not have to choose a single source of revenue. Many can combine hardware sales, subscriptions and enterprise services. The following models illustrate the principal strategic options.

Model A: Hardware-only or predominantly hardware revenue

How it works: The company sells the device and provides basic software without requiring a paid subscription for core functionality.

Revenue sources: Device sales, accessories, replacement products and potentially broader ecosystem purchases.

Advantages: Straightforward pricing, fewer recurring-billing barriers and an opportunity to use an established distribution network.

Risks: Revenue can depend heavily on product launches, replacement cycles, price competition and manufacturing economics.

Best suited to: Established electronics manufacturers and companies that can earn revenue from an entire ecosystem of products and services.

Model B: Hardware plus mandatory subscription

How it works: The user purchases, finances or receives compatible hardware while paying a continuing fee for core analytics, personalized insights or coaching.

Revenue sources: Hardware sales and recurring membership fees.

Advantages: A combination of upfront revenue and recurring income, potentially supported by high-margin software services.

Risks: Subscription fatigue, cancellations, dissatisfaction with restricted features and dependence on the company continuing to provide meaningful value.

Best suited to: Companies that can demonstrate continuing value through new insights, coaching, longitudinal data analysis and regular feature improvements.

Model C: Freemium health apps

How it works: Basic tracking or educational content is free, while advanced analytics, personalized plans, detailed reports or AI coaching require payment.

Revenue sources: Premium subscriptions, in-app purchases and optional specialist services.

Advantages: A lower barrier to initial adoption and the ability to segment customers according to their willingness to pay.

Risks: High download numbers may not convert into paying users. Free users can also create support and infrastructure costs.

Best suited to: Apps with a clearly differentiated premium feature and evidence that paid functionality improves the user's experience.

Model D: AI health coaching subscriptions

How it works: AI combines wearable measurements, user-entered information and contextual data to provide explanations, reminders, plans and conversational support.

Revenue sources: Monthly or annual subscriptions, premium coaching tiers or bundled access through a wearable membership.

Advantages: The software can potentially serve many users and personalize interactions at a scale that would be expensive with human-only coaching.

Risks: Incorrect recommendations, hallucinations, privacy concerns, weak engagement and unproven claims about clinical outcomes.

Best suited to: Platforms with well-defined use cases, reliable data, appropriate guardrails and measurable results.

Model E: Employer and corporate wellness

How it works: Employers purchase access to wearable programs, activity challenges, coaching and aggregated wellness reporting for eligible employees.

Revenue sources: Per-member-per-month contracts, enterprise licensing, platform fees and professional services.

Advantages: Potentially larger contracts and lower dependence on individual consumer subscription decisions.

Risks: Long sales cycles, procurement requirements, uncertain return on investment and employee concerns about data privacy.

Best suited to: Vendors that can demonstrate engagement, protect employee confidentiality and measure outcomes relevant to the purchasing organization.

Model F: Healthcare and remote patient monitoring

How it works: A validated device or platform supports a defined care pathway, including monitoring, clinician review or communication between patients and healthcare professionals.

Revenue sources: Enterprise contracts, implementation fees, clinical service fees and eligible reimbursement arrangements where applicable.

Advantages: Clinical workflows can create deeper integration and potentially higher switching costs.

Risks: Regulatory obligations, clinical safety requirements, cybersecurity risks, integration costs and uncertainty over reimbursement or adoption.

Best suited to: Companies with validated use cases, appropriate regulatory status and a clear role in the healthcare workflow.

Model G: Research, licensing and data-enabled partnerships

How it works: Companies collaborate with universities, healthcare providers or commercial partners on research, algorithm development or licensed technology.

Revenue sources: Research contracts, licensing fees, enterprise agreements and sponsored projects.

Advantages: Revenue diversification and opportunities to develop new products or establish scientific credibility.

Risks: Research income may be irregular. Data-sharing arrangements require robust privacy controls, appropriate consent and clear governance.

Best suited to: Platforms with high-quality longitudinal data, credible research capabilities and transparent data-use practices.

8. Subscription Revenue: The Metrics That Matter

Subscription revenue is often described as recurring and predictable. That description is justified only when customers continue paying and the company can serve them profitably.

Annual recurring revenue (ARR)

ARR estimates the annualized value of active recurring subscriptions at a particular point in time.

A simplified calculation is:

ARR = Active paying subscribers × Average monthly recurring subscription revenue × 12

For example, one million continuously active subscribers paying an average of US$6 per month would imply approximately US$72 million in annualized subscription revenue.

This is an illustrative run rate, not recognized accounting revenue or a prediction. It assumes all one million subscribers remain active, pay the stated average and are measured consistently, with no adjustments for discounts, refunds or changes in subscription mix.

Monthly recurring revenue (MRR)

MRR measures recurring subscription revenue for a given month. It helps analysts monitor growth, downgrades, cancellations and the effects of changes in pricing.

Subscriber retention and churn

Retention measures the proportion of subscribers who remain customers over a defined period. Churn measures the proportion who leave.

For wearable companies, retention should be examined by acquisition cohort, subscription plan, geography and device generation wherever reliable data are available.

A company can report a growing subscriber base while still experiencing high churn if new customer acquisition is strong enough to replace lost subscribers.

Customer acquisition cost (CAC)

CAC estimates how much a company spends to acquire a customer. It can include advertising, promotions, commissions and relevant sales expenditure.

For wearable businesses, the analysis should account for both hardware and digital-service acquisition economics.

A low subscription CAC may be misleading if the company depends on expensive hardware discounts, retailer incentives or substantial product-launch marketing.

Lifetime value (LTV)

LTV estimates the economic contribution expected from a customer over the duration of the relationship.

A common simplified approach uses the contribution margin generated by a customer over the expected retention period. Reliable estimates require realistic churn assumptions, service costs and cohort data.

LTV/CAC is not automatically meaningful just because it is above 1. Analysts must understand which costs are included and whether the calculation uses gross profit, contribution profit or revenue.

Hardware and membership gross margins

Hardware margin measures what remains after the direct costs assigned to producing and selling the device. Subscription gross margin measures the corresponding contribution after the costs assigned to providing the service.

The two margins should be examined separately. A high-margin subscription business can coexist with expensive hardware production, warranty claims, replacement costs or high corporate operating expenses.

Other important operating metrics

• Device activation and trial-to-paid conversion rates.
• Paid subscriber growth by cohort.
• Annual-plan versus monthly-plan mix.
• Subscription renewal and cancellation rates.
• Hardware return rates, warranty costs and replacement frequency.
• Engagement with premium features and AI coaching.
• Customer acquisition payback period.
• Support costs per subscriber.
• Gross margin and free cash flow over time.
• Concentration in app stores, retailers and other distribution channels.

9. How Strong Is the Scientific Evidence for Wearables?

Wearable health technology should be evaluated using more than a company's product demonstrations or app-store reviews. The scientific question is whether a device measures a particular signal adequately, whether its algorithm is valid and whether acting on its output improves a meaningful outcome.

Evidence level 1: Sensor measurement accuracy

This asks whether the sensor produces measurements that agree sufficiently with an appropriate reference method under defined conditions.

Examples include comparing a device's heart-rate readings with ECG measurements or evaluating sleep estimates against polysomnography.

Accuracy can differ between devices, individuals and settings. A device may perform well at rest but less reliably during exercise, or perform differently across skin tones, movement patterns and other user characteristics.

Evidence level 2: Algorithm validity

A device can measure a signal accurately while generating an unreliable interpretation of that signal.

For example, estimating sleep stages requires more than detecting motion or a change in heart rate. An algorithm must be tested against suitable reference measurements in relevant populations.

Similarly, a proprietary recovery score may be useful for a fitness routine without being a validated measure of disease risk or readiness for a particular medical intervention.

Evidence level 3: Clinical validity

Clinical validity asks whether a metric or algorithm reliably identifies, predicts or classifies a clinically meaningful condition in the population where it is intended to be used.

A relationship between a physiological signal and a disease does not automatically establish that a consumer device can diagnose that disease. False positives, false negatives and changes in disease prevalence can influence real-world performance.

Evidence level 4: Clinical utility

Clinical utility asks whether using the device improves decisions or outcomes compared with an appropriate alternative.

A device could measure a physiological variable accurately yet provide little additional benefit if the information does not change behavior, influence treatment decisions or improve patient care.

Evidence level 5: Real-world health outcomes

The strongest evidence for a health intervention generally comes from appropriately designed studies examining outcomes that matter to people, such as improved physical activity, quality of life, reduced complications or better disease management.

Clinical outcome evidence should be evaluated separately from device accuracy and product engagement.

10. What the Research Actually Shows

Consumer wearable accuracy is uneven

A living umbrella review published in Sports Medicine in 2024 examined 24 systematic reviews covering hundreds of thousands of participants across consumer wearable-validation studies.

Its findings showed that measurement performance varied by metric and device. Heart-rate estimates could perform reasonably well under certain conditions, while other measurements, including energy expenditure, physical activity intensity and sleep parameters, showed important errors or systematic bias.

The authors identified a substantial validation gap: among 310 consumer wearable devices identified in their review, only 34 had been validated for at least one biometric outcome in the included primary research. This was an estimate from that review's evidence base, not a claim that only 34 devices have ever been tested or that all current devices share the same limitations.

Source: Doherty et al., Keeping Pace with Wearables: A Living Umbrella Review of Systematic Reviews Evaluating the Accuracy of Consumer Wearable Technologies in Health Measurement, Sports Medicine (2024).

Read the full open-access review.

Smart rings: promising measurements, but important limitations

A systematic review of smart rings in clinical medicine, published in 2025, assessed 107 studies and reported promising results in several monitoring applications. However, it also identified substantial methodological limitations.

The review reported that 65% of included studies had moderate-to-high risk of bias. Other concerns included small samples, proprietary algorithms, limited reporting of participant diversity and declining adherence over time.

Its findings should therefore be interpreted as evidence of research progress rather than definitive proof that smart rings can diagnose or predict a broad range of diseases in routine practice.

Source: Smart Ring in Clinical Medicine: A Systematic Review.

Wearables can encourage physical activity

An umbrella review published in Physiological Reviews in 2026 synthesized 39 systematic reviews covering 98 original studies, most of which were randomized controlled trials.

The findings suggested that interventions incorporating wrist-worn activity trackers can increase physical activity. However, the evidence for improvements in cardiometabolic risk markers, quality of life, depression, anxiety and pain was limited or inconsistent. Many studies also included behavioral support alongside the wearable, making it difficult to attribute any improvement to the device alone.

Source: An umbrella review of systematic reviews of the impact of wrist-worn wearables on health outcomes.

The business implication is important: a device may support a useful behavior-change program without independently proving that it prevents or treats disease.

Sleep tracking is not equivalent to a sleep study

Consumer wearables estimate sleep using combinations of movement, heart rate and other physiological signals. Clinical sleep studies use more extensive measurements, including brain activity, to characterize sleep stages.

A meta-analysis comparing consumer wrist-worn sleep trackers with polysomnography found discrepancies across several sleep measures. Results from one device or population should not be assumed to apply to every ring or wearable.

Source: Performance of consumer wrist-worn sleep tracking devices compared to polysomnography: a meta-analysis.

Sleep trackers can still be useful for observing broad trends and encouraging consistent routines. They should not replace a clinical assessment when persistent insomnia, excessive daytime sleepiness, suspected sleep apnea or another sleep disorder warrants evaluation.

11. AI Coaching: When Does Personalization Create Real Value?

AI-powered coaching is a potentially attractive commercial layer because it transforms passive monitoring into an interactive service.

Instead of showing a user a heart-rate or sleep graph, an AI-enabled app might explain what changed, ask about recent behaviors and suggest a manageable adjustment to a routine.

However, personalization should not be confused with accuracy or effectiveness.

Where AI may add value

• Trend summaries: Explaining changes in a person's own recorded metrics.
• Behavioral support: Helping users set goals, monitor habits and maintain routines.
• Contextual explanations: Helping users interpret measurements alongside exercise, sleep schedules or self-reported events.
• Convenience: Reducing the time required to navigate charts and reports.
• Appropriate escalation: Directing users to professional advice when reported symptoms or device outputs warrant further assessment.

Where AI claims need more evidence

• Predicting a specific disease before symptoms arise in a general consumer population.
• Claiming to detect a condition without adequate independent validation.
• Recommending treatment changes based on an unvalidated score.
• Claiming that an AI coach produces better health outcomes than a simpler app or usual care without comparative studies.
• Using biological-age or longevity scores as if they were proven measures of future lifespan.

The key question is not whether a platform uses AI. It is whether the complete system—sensor, algorithm, interface and recommendation—has been tested for its intended purpose.

12. The Emerging Opportunity: Connecting Wearable Data to Healthcare

Consumer wearables may become more commercially valuable when they support clearly defined healthcare workflows instead of remaining isolated lifestyle gadgets.

Potential applications include:

• Monitoring selected measurements between clinical appointments.
• Supporting rehabilitation and physical-activity programs.
• Helping research participants record longitudinal measurements.
• Supporting sleep and stress-management interventions.
• Integrating appropriate wearable data with patient-reported outcomes.
• Helping healthcare teams identify changes that require further assessment.

These opportunities depend on the clinical context. A consumer wellness device should not automatically be treated as suitable for diagnosis, treatment decisions or medical monitoring.

In October 2026, Reuters reported that Oura had announced a clinical trial investigating relationships between smart-ring data and outcomes among people receiving obesity treatments, including GLP-1 medications and bariatric surgery.

The planned study illustrates how wearable platforms may seek evidence for more specialized healthcare applications. An announced trial, however, is not a completed study and does not establish that the approach improves treatment outcomes.

Source: Reuters, October 28, 2026.

13. Regulation, Medical Claims and Data Privacy

Regulatory classification depends on a product's intended use, claims, functions and the jurisdiction in which it is marketed.

In the United States, the FDA issued updated guidance on general-wellness products in January 2026. Its policy describes the agency's approach to certain low-risk products intended to promote a healthy lifestyle and distinguishes these products from functions intended for diagnosing, curing, mitigating, preventing or treating disease.

This distinction matters because a device marketed for general wellness does not become a clinically validated diagnostic product merely because it measures physiological signals or uses AI.

Source: FDA, General Wellness: Policy for Low Risk Devices, January 2026.

Privacy is part of the business model

Wearables can collect sensitive longitudinal information, including sleep patterns, physiological measurements, activity routines and, depending on the product, reproductive-health information.

Companies should explain:

• What information is collected and how long it is retained.
• Whether information is processed on the device or transmitted to cloud services.
• Whether data are used to develop or improve AI models.
• Which third parties may receive information and for what purposes.
• How users can export their data, withdraw consent or delete their accounts.
• Whether employers, insurers or other partners can access individual-level information.

Privacy practices can influence adoption, retention and regulatory exposure. A strong recurring-revenue model built on consumer trust can be undermined if users do not understand how their information is used.

14. Investment Analysis: How to Evaluate a Wearable-Health Company

For investors, the central question is whether the company can turn demand for health monitoring into durable and profitable customer relationships.

Revenue quality

Examine the proportion of revenue from hardware, subscriptions and enterprise services. Determine whether recurring revenue is growing because the existing customer base retains and upgrades, or because the business is continually acquiring new hardware customers.

Retention quality

Look for disclosed cohort retention, renewal rates, cancellation trends and engagement data. A large subscriber count is not sufficient without understanding how long users remain paying customers.

Unit economics

Assess hardware gross margin, subscription gross margin, marketing expenditure, customer acquisition payback, warranty costs and replacement rates. Request clear definitions of management's non-GAAP measures and customer lifetime value calculations.

Scientific credibility

Separate peer-reviewed validation from company-sponsored research, preliminary findings, retrospective analyses and testimonials. Check whether research tested the exact product, algorithm and intended use that the company currently markets.

Competitive moat

Potential advantages include brand recognition, sensor and algorithm expertise, comfortable hardware, proprietary software, customer retention, distribution and useful integrations.

Accumulated data can be an asset, but a large dataset is not inherently a scientific moat. Its quality, diversity, relevance, lawful use and ability to improve a validated product determine its practical value.

Regulatory and execution risk

Evaluate the company's exposure to medical-device regulation, privacy laws, product claims, cybersecurity, manufacturing reliability and dependence on third-party distribution platforms.

Valuation discipline

Rapid revenue growth does not by itself justify an attractive investment valuation. Investors must compare the price with sustainable earnings, cash flow, recurring revenue quality, competitive threats and the capital needed to maintain growth.

Private-company valuations and proposed IPO terms should be distinguished from prices at which public-market investors can actually transact.

15. Which Business Model Looks Most Sustainable?

There is no universally superior model. The best structure depends on customer expectations, hardware economics, service costs, distribution strength and the clinical or lifestyle problem being solved.

For established consumer-electronics manufacturers

A device-first model with optional services can be attractive when a company already has a large installed base and earns revenue from complementary products. A subscription is most compelling when the premium features offer meaningful value beyond basic tracking.

For focused wearable-health companies

A hardware-plus-subscription model can work when the device generates valuable longitudinal data and the software continually improves the customer experience. Its sustainability depends on retention, customer trust and disciplined hardware economics.

For software-first AI health apps

A freemium model can expand distribution, while subscriptions support coaching and specialized analytics. The challenge is converting engagement into payment without making unsupported medical claims or creating unnecessary anxiety through constant monitoring.

For clinical platforms

Enterprise contracts and healthcare partnerships may offer more durable opportunities where the product addresses a validated clinical need. These contracts often require stronger evidence, privacy safeguards, integration and implementation capabilities.

Overall assessment: The most attractive long-term businesses are likely to combine reliable measurements, useful interpretation, sustained customer engagement and defensible distribution. Recurring revenue strengthens the model only when users continue receiving value.

16. Practical Checklist for Consumers

Before buying a smart ring or paying for an AI wearable-health subscription, consider the following questions.

• What do I actually need? Sleep trends, fitness monitoring, recovery feedback, a specific medically relevant measurement or something else?
• Does the device have evidence for that measurement? Check independent validation for the particular feature rather than relying on a broad accuracy claim.
• What is the total cost? Include hardware, subscription renewals, optional features and potential replacement costs.
• What happens if I cancel? Determine which metrics, reports and historical information remain accessible.
• Can I export my data? Portability helps reduce dependence on one company's platform.
• How is my information protected? Read the privacy policy, data-sharing terms and available deletion controls.
• Will the information change what I do? A device that encourages useful behavior may be more valuable than one that produces many scores without actionable meaning.

For consumers in Malaysia and elsewhere outside the United States, subscription pricing, product availability, payment terms and access to regulated features may differ. Verify local terms directly with the manufacturer.

17. Frequently Asked Questions

Are smart rings profitable businesses?

They can be, but profitability depends on manufacturing costs, retail pricing, acquisition costs, warranty expenditure, customer retention and software margins. Oura's 2026 filing illustrates how hardware sales and a high-margin membership business can coexist. Its financial results should not be assumed to represent every smart-ring manufacturer.

Which smart rings require a subscription?

Subscription policies depend on the manufacturer and product. Oura requires membership for access to its full app experience; WHOOP structures its offering around paid memberships; Samsung states that Galaxy Ring health data are available through Samsung Health without an additional ring-data subscription; and Ultrahuman offers core Ring AIR functionality without a mandatory data subscription, alongside optional paid features.

How do smart-ring companies make recurring revenue?

They can charge for premium health insights, longitudinal reports, personalized analytics, AI coaching and specialized software services. Some manufacturers also use membership bundles that include compatible hardware.

Can AI wearables diagnose disease?

Not simply because they collect biometric data or use AI. A diagnostic claim requires appropriate validation and regulatory consideration for the intended use and market. General wellness measurements and scores should not be treated as substitutes for medical evaluation.

Are smart rings more accurate than smartwatches?

There is no universal answer. Performance depends on the device, measurement, sensor design, algorithm, user and conditions. Evidence for one metric cannot establish that a particular ring is superior across sleep, heart rate, activity and other measurements.

Do wearable health apps actually improve health?

Evidence suggests that activity-tracker interventions can increase physical activity in some populations. Evidence for broader outcomes, including cardiometabolic risk markers and quality of life, is less consistent. Benefits depend on the intervention, user population, adherence and the outcome measured.

Is a high subscription gross margin enough to justify an investment?

No. Gross margin is only one part of the analysis. Investors must also assess growth quality, retention, acquisition costs, hardware economics, operating expenses, cash flow, competition and valuation.

What is the biggest risk for an AI wearable company?

There are several. Commercial risks include subscription fatigue, weak retention and price competition. Scientific and regulatory risks include inaccurate measurements, unvalidated health claims and inappropriate recommendations. Privacy failures can damage consumer trust and create additional costs.

Conclusion: The Future Is Health Intelligence, Not Just Health Tracking

Smart rings, AI wearables and health apps are evolving from standalone monitoring products into connected platforms for continuous health information and personalized services.

The business opportunity is significant because a device sale can introduce a long-term customer relationship. Memberships, AI coaching, premium analytics and healthcare partnerships can extend that relationship and diversify revenue beyond hardware sales.

Oura illustrates the potential of combining hardware with recurring membership revenue. WHOOP demonstrates a membership-led approach, while Samsung and Ultrahuman illustrate alternative ways to monetize the core device and optional services.

The evidence, however, must remain separate from the commercial narrative. Reliable sensor measurements are not the same as validated predictions, and validated predictions are not necessarily evidence of improved clinical outcomes.

For investors, the most useful framework combines recurring-revenue economics with scientific credibility. For consumers, the most useful device is not necessarily the one with the greatest number of metrics, but the one that provides reliable, understandable information relevant to their goals.

The central investment and consumer question is the same: Does the platform create enough measurable, sustained value to justify its cost?

That question—not the presence of AI, the number of sensors or the size of the subscriber headline—will ultimately determine which wearable-health businesses can build durable competitive advantages.

Sources and Further Reading

1. Oura Inc. — SEC registration statement and financial disclosures (2026)
2. Oura — Official membership pricing and features
3. WHOOP — Official membership pricing
4. Samsung — Galaxy Ring product information
5. Ultrahuman — Ring AIR pricing and optional features
6. Sensor Tower — State of Wearable Technology 2026
7. Doherty et al. — Consumer wearable measurement accuracy review, Sports Medicine (2024)
8. Smart Ring in Clinical Medicine: A Systematic Review (2025)
9. Umbrella review of wrist-worn wearables and health outcomes (2026)
10. Meta-analysis of consumer sleep trackers compared with polysomnography
11. US FDA — General Wellness: Policy for Low Risk Devices (January 2026)
12. Reuters — Oura's planned study of ring data and obesity-treatment outcomes (October 28, 2026)

Editorial note: This article is for educational and informational purposes. It is not medical advice, investment advice or an endorsement of any specific wearable. Company-reported financial information, manufacturer product claims and research findings should be assessed in their respective contexts. Prices and features may change after publication.